Skip to content
Recall Observatory FDA recall evidence

Drug product

Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80

D-0845-2022

April 12, 2022

Class I

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 89970
Status
Terminated
Classification
Class I
Quantity
89,665 vials
Official record key
drug-enforcement:D-0845-2022

Official wording

Reason: Labeling: Missing label on the vial

Code information: Lot #: BF21002800, Exp 8/2023

Distribution pattern: USA nationwide.

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Missing